TDB Funds Clearsynth for Deuterated Chemical Facility

In a major leap for India’s chemical innovation, the Technology Development Board (TDB) has extended financial support to Clearsynth Labs Limited. This funding will help set up a dedicated bulk manufacturing facility for deuterated reagents and building blocks—a vital component in advanced research and high-tech applications.

Deuterated Compounds: A Rising Global Demand

Deuterium-based compounds are gaining momentum worldwide. Not only are they essential in pharmaceutical research, but they are also critical in OLED technology, semiconductors, and fiber optics.

Although India has a strong pharmaceutical sector, it still imports most of its deuterated solvents. Consequently, the country remains dependent on foreign suppliers for high-purity, isotope-labelled materials. This project aims to change that.

Bridging the Import Gap

With TDB’s support, Clearsynth will establish an indigenous production facility. This plant is expected to:

Reduce India’s import dependency
Improve access to specialty chemicals
Create export opportunities for local manufacturers

More importantly, it aligns with the goals of Atmanirbhar Bharat and Make in India by fostering innovation and self-reliance.

A Strategic Tie-Up for Sustainability

Furthermore, Clearsynth has entered into a long-term agreement with the Heavy Water Board (HWB) under the Department of Atomic Energy. This ensures a consistent supply of high-quality heavy water—essential for manufacturing deuterated reagents at scale.

As a result, the facility gains a significant competitive edge in terms of both cost and capacity.

Key Advantages of the Project

Thanks to this initiative, India can finally position itself as a global supplier in a high-value niche market. The project offers multiple benefits:

Encourages domestic innovation and IP creation
Saves valuable foreign exchange
Generates high-skilled jobs in R&D and manufacturing
Meets rising global demand in a timely and cost-effective manner

Moreover, this project sets the tone for future investments in advanced specialty chemicals.

Voices of Leadership

Shri Rajesh Kumar Pathak, Secretary of TDB, remarked:

“This initiative enables India to capitalize on the rapidly expanding market for deuterated compounds. TDB’s support is crucial in building a world-class facility.”

Meanwhile, Mr. Vijay Ambati, MD & CEO of Clearsynth, shared:

“Creating deuterated solvents that meet global standards is complex and costly. However, with TDB’s assistance, we are confident in our ability to build a competitive, scalable model.”

Unlocking India’s Potential in High-Tech Chemistry

With global demand rising fast, India has a timely opportunity to lead in high-purity, isotope-labelled compounds. The Clearsynth facility is more than just a manufacturing unit—it represents a shift in how India approaches strategic technologies and chemical sovereignty.

Going forward, this initiative will encourage more private players to invest in cutting-edge sectors that were previously import-heavy. It also sets a new benchmark for public-private partnerships in science and technology.